No Data
No Data
Morgan Stanley Sees $180B Patent Cliff, $380B Deal Capacity Fueling Biopharma M&A
Financial Stocks Deliver Profits in Q2 Amid Rebound in Investments - Earnings Scorecard
Lots of Earnings, Price of Stamps Increasing: What to Watch
Unlocking Q2 Potential of Johnson & Johnson (JNJ): Exploring Wall Street Estimates for Key Metrics
Stifel Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $155
Stifel analyst Rick Wise maintains $Johnson & Johnson(JNJ.US)$ with a hold rating, and maintains the target price at $155.According to TipRanks data, the analyst has a success rate of 57.5% and a
Earnings Preview: JNJ to Report Financial Results Pre-market on July 17
$Johnson & Johnson(JNJ.US)$ is scheduled to release its financial results pre-market on July 17. Earnings PreviewAnalysts estimate $Johnson & Johnson(JNJ.US)$ to post revenue of USD22.31 billion for 2
loading...
No Data
103966930 : recurriny revenue in long term ,should be a good news
Stock_DriftOP 103966930: I agree.